Journal of Pharmacovigilance and Quality Assurance ISSN: 3108-2343 (Online)

Authors: Dr. Neelam Katariya, Suman Bhanot, Leena Singh

Abstract: Medicines and vaccines are critical components of the nation's healthcare system. Deadly episodes in the past, such as the thalidomide catastrophe in 1950, the usage of lash lure mascara, and ethylene glycol toxicity in children, mandated and highlighted the necessity of medication and vaccination safety. Pharmacovigilance is a rigorous procedure that deals with medication safety throughout the medicine's life cycle. Intrinsic limitation up to phase III of the drug discovery process underlines the importance of pharmacovigilance. The current essay attempts to emphasise crucial aspects of the safety process during medication development and its future, and it will aid drug prescribers and users to some extent concerning the effective and safe use of pharmaceuticals in daily life.

Keywords: Drug Safety, Pharmacovigilance, Nation Healthcare System, Drug Discovery Process 

Authors: Atul Chouhan, Kapil Choudhary 

Abstract: Ayurvedic medicines play an important part in illness treatment; they originated in India and are now widely used in other countries. Pharmacovigilance is concerned with the detection, assessment, comprehension, and prevention of adverse medication reactions and associated difficulties. The world is becoming more aware of the importance of developing pharmacovigilance for herbal medications. Using normal pharmacovigilance methodologies (WHO standards) introduces new issues linked to how herbal medications are controlled, used, identified, and perceived. The primary approach of detection is now correct reporting of possible adverse medication responses to herbal medicines. However, there is under-reporting for herbal medications since individuals do not seek expert counsel or record side effects. An ADR is described as a detrimental or noxious reaction to a marketed health product that occurs at dosages routinely used or evaluated for the treatment, diagnosis, or prevention of a disease or the alteration of an organic function. Plants are crucial in the creation of contemporary medications. More than 65-70 percent of current medications sold throughout the world are derived or created directly or indirectly from plant sources. Ginkgo biloba causes bleeding, Ephedra (Ma Huang) causes hypertension, sleeplessness, arrhythmia, and other side effects. With one or more clinical trials and other clinical research activities being undertaken in India, there is an urgent need to comprehend the significance of pharmacovigilance and how it affects the product's lifecycle. In this case, the DCGI should respond immediately to improve pharmacovigilance by incorporating Good Pharmacovigilance Practice into processes and procedures to assist assure regulatory compliance, as well as to improve clinical trial safety and postmarketing surveillance. When healthcare experts, regulatory agencies, pharmaceutical firms, and consumers cooperate, it will be beneficial.

Keywords: Herbal medicine, ADR, Pharmacovigilance, WHO.

Authors: Dr. Chandani Rawat, Piyush Jain, Abhishek Mehta

Abstract: Pharmacovigilance is becoming more prevalent in India. Given the scale of the Indian pharmaceutical business, it is critical to understand how pharmacovigilance affects pharmaceutical goods. Pharmacovigilance contributes to the safe use of pharmaceutical products, however under reporting is a big issue in India, either to a lack of information or a fear of the unknown. To develop a strong pharmacovigilance system in India, both the Indian pharmaceutical industry and the government must participate actively. Initiatives that can aid tiny privatised generic enterprises in dealing with changing laws, given their low budget, are required. This article presents an overview of India's current pharmacovigilance system, its difficulties, and how those problems can be overcome if India adopts the pharmacovigilance procedures used by other developed and developing countries.

Keywords: Adverse Drug Reaction, Central Drugs Standard Control Organization, Pharmacovigilance,

Authors: Vandana Porwal, Preeti Khandelwal

Abstract: Haemovigilance is critical in ensuring patient safety when receiving blood transfusions. Haemovigilance is a systematic approach of watching, recognising, reporting, investigating, and analysing adverse occurrences and reactions related to blood transfusion and blood product manufacture. This system is also a fundamental component of blood system quality control, bringing about counteractive and preventative actions, as well as the continuous improvement of the quality and safety of blood products and the transfusion process. The data supplied by the haemovigilance system aids in the formulation of significant modifications in the entire blood transfusion process that are beneficial to patient safety. This page briefly explains the history of haemovigilance, the importance of haemovigilance, and the Indian Haemovigilance programme.

Keywords: CDSCO, PvPI, Blood transfusion, Adverse drug reaction.

Authors: Aryan Kulkarani, Abhishek Sinha, Rupa Kulkarani

Abstract: In clinical practise, this entails having a well-organized Pharmacovigilance system in place. Pharmacovigilance is a crucial activity for monitoring drug-related concerns after they have been sold in the "real world." Pharmacovigilance and all drug-related concerns are critical for everybody whose life is affected in some manner by medical treatments. An organised Adverse Drug Reaction monitoring programme is one mechanism for more actively detecting ADRs and, as a result, improving patient care quality. The numerous processes for evaluating and monitoring the safety of medications in clinical use are critical for preventing or lessening damage to patients and enhancing public health. Adverse drug reactions (ADRs) have a significant influence on public health, decreasing patients' quality of life and laying a significant financial burden on health care systems at a time when many are under financial duress. All healthcare practitioners have a role to play in balancing the advantages and hazards of a drug. Once a medicine is offered to the public, determining its safety is the joint duty of all those involved in the prescription process, including patients. Healthcare practitioners play an important role in collecting and reporting suspected ADRs so that regulatory bodies are notified of potential safety issues, allowing for early and appropriate action. Pharmacovigilance is a crucial activity for monitoring drug-related concerns after they have been sold in the "real world." Pharmacovigilance and all drug-related concerns are critical for everybody whose life is affected in some manner by medical treatments. This study discusses many issues of monitoring and evaluating adverse medication reactions in clinical settings.

Keywords: Drug, Adverse drug reactions, Pharmacovigilance.

Authors: Vidya Bansal, Akarti Pathak

Abstract: Pharmacovigilance is defined by the World Health Organization (WHO) as "the research and practises connected to the detection, evaluation, understanding, and prevention of adverse effects or other potential drug-related issues." As an integral element of the system, pharmacovigilance plays a crucial role in assuring patients' medication safety. Adverse Medication Reaction (ADR) is defined by WHO as any adverse and unanticipated response to a drug that occurs at levels commonly used in man for disease prevention, diagnosis, or therapy, or the alteration of physiological function.

 

Pharmacovigilance could identify complete information on unexpected and serious adverse events by evaluating medication impact. Due to time constraints and other variables, it would be impossible to discover all pharmacological effects during an in-vivo clinical study. Pharmacists perform more than just formulating and delivering medications. They play an incalculable significance in the pharmaceutical sector and clinical research. The practise of pharmacy extended well beyond community service. Pharmacist play a paramount role in pharmacovigilance. Their position in pharmacovigilance differs by nation, but their primary purpose is to serve for the community's safety. Pharmacists may build a trusted environment by advising patients, eliminating prescription mistakes, and improving the patient's safety and quality of life.

Keywords: Pharmacist, Adverse Drug Reactions (ADRs), Prophylaxis, Pharmacovigilance, 

Authors: Deepika Rao, Aditya Sharma

ABSTRACT: Good Manufacturing Practices (GMP) are integral to ensuring the safety, quality, and efficacy of pharmaceutical products. Quality assurance (QA) within GMP frameworks provides systematic procedures to prevent errors, contamination, and deviations in drug manufacturing. This paper explores the principles, components, and implementation strategies of QA in GMP, emphasizing risk management, documentation, validation, and continuous improvement. Tables illustrate critical GMP areas, QA responsibilities, and compliance assessment. The paper also discusses challenges in GMP adherence and proposes strategies to strengthen QA practices. By integrating QA into GMP, manufacturers can maintain product integrity, meet regulatory standards, and safeguard patient health.

KEYWORDS: Good Manufacturing Practices, Quality Assurance, Pharmaceutical Manufacturing, Compliance, Validation, Risk Management.

Authors: Priya Nair, Vikram Singh

ABSTRACT: Quality assurance (QA) in clinical data management and documentation is critical to ensure the integrity, reliability, and regulatory compliance of clinical trials. Accurate, complete, and consistent data support decision making for drug development, safety assessments, and regulatory submissions. This paper explores QA strategies in clinical data management, focusing on data validation, monitoring, audit trails, and regulatory adherence. Tables illustrate QA processes, documentation standards, and common errors with mitigation approaches. Challenges such as human errors, technological limitations, and regulatory complexities are addressed. Emphasis is placed on implementing robust QA frameworks, electronic data capture systems, staff training, and continuous monitoring to enhance data quality and reliability in clinical research.

KEYWORDS: Quality Assurance, Clinical Data Management, Documentation, Regulatory Compliance, Data Validation, Audit Trails, Electronic Data Capture.

Authors: Vishal Baman, Shivani Kshatriya, Heena Ninama, Mitali Dalwadi, Dr. Umesh Upadhyay

Abstract: Quality by Design is the current method for best of pharmaceuticals. This paper gives concept approximately the Pharmaceutical Quality by Design (QbD). The Quality by Design is defined and a number of its factors recognized. Process parameters and best attributes are diagnosed for every unit operation. Benefits, possibilities and steps concerned in Quality by Design of Pharmaceutical products are defined. The purpose of the pharmaceutical improvement is to layout a great product and its production method to constantly supply the supposed overall performance of the product. Quality can't be examined into products however quality has to be built in by layout. It consists of the Quality target product profile, crucial quality attributes and key elements of Quality by Design. It additionally gives evaluation among product quality by end product checking out and product quality through Quality by Design. The basis of Quality by Design is ICH Guidelines. It is primarily based totally on the ICH Guidelines.

Q8 for pharmaceutical improvement,

Q9 for quality risk management,

Q10 for pharmaceutical quality systems. It additionally offers application of Quality by Design in pharmaceutical improvement and production of pharmaceuticals.

Keywords: Quality by Design, Process Analytical Technology, Quality target product profile, Critical Quality Attributes

Authors: Shivani Kshatriya, Heena Ninama, Mitali Dalwadi, Dr. Umesh Upadhyay

Abstract: Quality by Design is the current method for quality of pharmaceuticals. The purpose of the pharmaceutical development is to design a quality product and its manufacturing method to constantly supply the intended overall performance of the product. Quality can't be examined into products however quality have to be built in through design. It is an important part of the current technique to pharmaceutical quality. Under this idea of QbD during designing and improvement of a product, it is important to define preference product overall performance profile [Target product Profile (TPP), Target Product Quality Profile (TPQP)] and identify important quality attributed (CQA). On the premise of this we will design the product components and process to satisfy the product attributes. This results in understand the effect of raw materials [critical material attributes (CMA)], critical process parameters (CPP) at the CQAs and identity and control sources of variability.

Keywords: Quality by design, Analysis, Regulatory 

Authors: Vaghela Kuldeepsinh, Mitali Dalwadi, Dr. Umesh Upadhyay

Abstract: X-ray spectrometry is a very important tool for scientific analysis. Whereas the earliest demonstration experiments were completed within the laboratory, with the arrival of cyclotron lightweight sources most of the experiments shifted to massive scale cyclotron facilities. Within the recent past there's associate raised interest to perform X-ray experiments conjointly with in-house laboratory sources, to alter access to X-ray absorption and X-ray emission spectrometry, particularly for routine measurements. Here we tend to summarize the recent developments and touch upon the foremost representative example experiments within the field of in-house laboratory X-ray spectrometry. We tend to 1st offer associate introduction and a few historic backgrounds on X-ray spectrometry. This is often followed by an outline of the detection techniques used for X-ray absorption and X-ray emission measurements. A brief paragraph conjointly puts connected high energy resolution and resonant techniques into context, although they're not however possible within the laboratory. At the top of this section the opportunities mistreatment wavelength dispersive X-ray spectrometry within the laboratory area unit mentioned. Then we tend to summarize the relevant details of the recent experimental laboratory setups split into 2 separate sections, one for the recent von Hamos setups, and one for the recent Johann/Johansson kind setups. Following that, absorption on chemistry and chemical change, we tend to then summarize a number of the notable X-ray absorption and X-ray emission experiments and also the results accomplished with in-house setups. In an exceedingly third half we tend to then discuss some applications of laboratory X-ray spectrometry with a selected specialize in chemistry and chemical change. [01]

Keywords: X-Ray Spectroscopy, Photons, Atoms, Amplifier, X-Ray detector

Authors; Radhika, Soni Sharma, Deepak Joshi

Abstract: Various studies have carried over niosomes from ancient times. The niosomes article focuses on the many benefits of vesicular systems in terms of improving the effective drug delivery system and achieving maximal therapeutic concentration. Niosomes are made because the surfactant has a better chemical stability than phospholipids made from liposomes. Niosomes are utilised as a medication carrier as well as to decrease drug adverse effects and achieve maximal effective concentration in the body for a variety of effects. The formulation of niosomes is utilised in a variety of ways, including intravenous, oral, transdermal, inhalation, ocular, and nasal delivery. Niosomes are nonionic surfactant vesicles with a lamellar structure that must give additional benefits. According to this article, niosomes are fully utilised for medication transport and therapeutic usage in the treatment and management of a wide range of serious illnesses.

Keywords: Niosomes, Vesicles, Vesicular system, Therapeutic Application, Entrapment

Author: Kushal Sharma

Abstract: Any undesirable and unexpected response to a medication that occurs at levels usually employed in man for prevention, diagnosis, or therapy of illness, or for the change of physiological function, is referred to as an adverse drug reaction (ADR). We would be able to identify and target particular areas for robust pharmacological treatment if we had a better grasp of the frequency and type of ADRs, as well as patient opinions on quality of life. Because ADRs are life-threatening, it is critical to understand the common medicines that cause them, their therapeutic class, demographic data on patients who have experienced ADRs, and the medications they are taking concurrently. ADR specific data, such as the type of reaction, the system impacted, and the likely reasons, will also be very useful in reducing ADRs. To maintain track of newly launched medicines and medical goods, the procedure of identifying and concluding regarding ADRs should be constant and continuing. Furthermore, if possible, strict pharmacological analysis, clinical data, and an in vivo investigation are also necessary. The focus of this article is on the unfavourable response and the techniques for assessing it.

Keywords: Pharmacovigilance program, Adverse drug reaction, Vigflow system, Medications

Author: Karanjkar Mayuri Bandu

Abstarct: Chromatography is the important technique of separation science  and used in all pharmaceutical industries and research laboratories. High Performance Liquid Chromatography is the most important technique used to identify, detect, separate and quantify the drug. There are various chromatographic parameters were analyzed like physiochemical properties of drug, chromatographic conditions, sample preparation, detection of analyte etc. Review the method development and validation of HPLC system is the main objective of these articles. Validation of HPLC method contains system suitability, specificity, linearity, range, accuracy, precision, robustness, LOD, LOQ. Validation of HPLC system is done as per ICH guidelines.

Keywords: Chromatography, HPLC, Validation, ICH guidelines.

Authors: Damini Vadnerkar, Devanshi Upadhyay, Prof. Mitali Dalwadi, Dr. Chainesh Shah, Dr. Umesh Upadhyay

Abstract: Impurity profiling is that the method of procure and evaluating data that establishes biological safety of a non-public impurity; thus, divulge its need and scope in pharmaceutical research. There isn't any clear definition for impurity within the pharmaceutical world. Impurity profiling includes identification, structure elucidation and quantitative determination of impurities and degradation products in bulk drug materials and pharmaceutical formulations. Impurity profiling has earn importance in modern pharmaceutical analysis because of the actual fact that unidentified, potentially toxic impurities are hazardous to health and then on extend the safety of drug therapy, impurities should be identified and determined by selective methods. Terms like residual solvents, by product, transformation products, degradation products, interaction products and related products are habitually accustomed define impurities. Identification of impurities is finished by diversity of Chromatographic and Spectroscopic techniques, either alone or along with other techniques. This review immerses various aspects related to the impurity profiling of a stuffed with life pharmaceutical ingredient.

Keywords: Impurity profiling, Impurities, Identification and isolation of impurities, validation, application

Authors: Devanshi Upadhyay, Damini Vadnerkar, Prof. Mitali Dalwadi, Dr. Chainesh Shah, nDr. Umesh Upadhyay

Abstract: Quality-by-design (QbD) may be a systematic approach to drug development, which begins with predefined objectives, and uses science and risk management approaches to realize product and process understanding and ultimately process control? The concept of QbDare often extended to analytical methods. The emphasis of AQbD approach is on understanding of the operation and the variables affecting Analytical Methods employed in product development and hence creating an extensive knowledge repository. The variables which affect the output are identified and subjected to thorough risk assessment employing various tools and techniques discussed within the article, after which the variables are optimized. The final method is validated and a control strategy is put in place. Additionally, global harmonization of QbD terms and explicit guidelines on implementation of the QbD approach in all fields of product development including Analytical Techniques is necessary to streamline the path towards embracing this unique and effective approach.

Keywords: Quality, Quality by Design, Analytical QbD, Method Operable Design Region (MODR.

Authors: Dr. Kavita Nair, Mr. Rohit Sen

ABSTRACT: Pharmaceutical risk-benefit analysis is a cornerstone of decision-making in modern drug development, regulatory approval, and clinical practice. It provides a structured framework for evaluating therapeutic efficacy against potential risks, ensuring that new and existing medications offer more benefits than harm to patients. With advances in pharmacovigilance, statistical modeling, real-world evidence, and patient-centered care, the methodologies for risk-benefit analysis have evolved significantly. This paper examines the conceptual foundations, methodologies, applications, challenges, and future directions of pharmaceutical risk-benefit analysis. It emphasizes the balance between innovation and safety, highlighting how effective frameworks can improve drug regulation, patient outcomes, and healthcare delivery.

KEYWORDS: Risk-Benefit Analysis, Pharmaceuticals, Patient Safety, Drug Efficacy, Regulatory Science

Authors: Dr. Priya Malhotra, Mr. Ankit Verma

ABSTRACT: Pharmaceutical regulatory inspections are critical tools for ensuring compliance with Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and Good Clinical Practices (GCP). Regulatory bodies such as the US FDA, EMA, and CDSCO conduct routine and for-cause inspections to verify that pharmaceutical organizations adhere to established quality, safety, and efficacy standards. This paper explores the principles, methodologies, and challenges of regulatory inspections and compliance in the pharmaceutical industry. Emphasis is placed on inspection types, preparation strategies, common findings, and corrective actions. Tables summarizing inspection processes, key compliance areas, and mitigation strategies are included. Effective regulatory compliance enhances patient safety, product quality, and global market access.

KEYWORDS: Regulatory Inspections, Pharmaceutical Compliance, GMP, GCP, GLP, Quality Assurance, Drug Safety

Authors: Pratik Kayasth, Dr. Jitendra Patel, Dr. Umesh Upadhyay

Abstract: ackaging of the pharmaceutical product is associated with an integral part of the pharmaceutical process. Packaging plays a crucial role within the protection of the internal contents of a pharmaceutical product to take care of the standard of product. Packaging of a product is additionally needed to differentiate between the various products of various makers. The packaging of a product ought to be convenient and compliant throughout the complete product lifecycle. Packaging helps to guard the contents from environmental exposure like light/moisture and mechanical stress throughout transportation. Numerous styles of packaging materials square measure offered like glass, metal, plastic etc. handiness of varied packaging instrumentation has helped the business to satisfy today’s needs of meeting the worldwide standards at a far quicker rate compared to ancient packaging. Container-closures also are necessary as they will act with the interior content directly. The foremost used material for closure is that the rubber-based closure system. Pharmaceutical packaging has a subject matter of continuous development continually and has undergone vital alterations from time to time attributable to the modernization of dose forms that need special packaging needs.

Keywords: Pharmaceutical Packaging, Categories of Packaging, Types of Packaging, Containers, Closures, Packaging Materials, Formulation aspects, Regulatory aspects.

Authors: Shivani Bhadoriya, Prof. Bhavna Joshi, Dr. Umesh Upadhyay

Abstract: Freeze-drying is a way of disposing of water via way of means of sublimation of ice crystals from frozen material. Suitable parameters of procedure application allow us to excellent quality products compared to products dried with the traditional methods. In the pharmaceutical discipline, lyophilization has come to be an essential situation for ongoing improvement and expansion. Lyophilization is common, however, value extensive and for this reason, one of the freeze-drying procedure improvements is to decrease the drying time (especially number one drying time, that’s the longest of the 3 steps in freeze-drying).

 

However, growing the shelf temperature into secondary drying earlier than all the ice is eliminated from the product will probably reason disintegrates or eutectic melt. Thus, from a product excellent in addition to procedure economics standpoint, it’s far very essential to locate the give up of number one drying. The overview centered on the latest advances and its objectives in close to future. At first, the principle, step involved, method components and significane of lyophilization, techniques of lyophilization with the detection of giving up factor in lyophilization become explained. In the 21st century, in the pharmaceutical discipline, lyophilization has come to be an essential situation for ongoing improvement and expansion. Lyophilization is common, however, value extensively. In vintage days procedure optimization become centered handiest on drying in preference to lyophilization. But lyophilization becomes more similarly essential for the procedure of pharmaceuticals.

Keywords: Freeze drying, Freeze drying methods, Lyophilization, Freeze Drying Equipment.

Authors: Het Patel, Prof, Mitali Dalwadi, Dr. U.M.Upadhyay 

Abstract: Chromatography is defined as a set of techniques which is used for the separation of constituents in a mixture. This technique involves 2 phases stationary and mobile phases. The separation of constituents is based on the difference between partition coefficients of the two phases. The chromatography term is derived from the Greek words, namely chroma (colour) and graphein (to write). Chromatography is a very popular technique and it is mostly used analytically. There are different types of chromatographic techniques, namely Paper Chromatography, Gas Chromatography, Liquid Chromatography, Thin Layer Chromatography (TLC), Ion exchange Chromatography and lastly, High-Performance Liquid Chromatography (HPLC). This review mainly focuses on the HPLC technique, its principle, types, instrumentation and applications. High-performance liquid chromatography is the most accurate method extensively used for the qualitative and quantitative analysis of drug products. Analytical method development and validation play vital role in the drug discovery, Drug development and manufacture of pharmaceuticals. A simple, precise, accurate, specific and RP-HPLC method was developed for the determination of drugs in pharmaceutical formulation.

Keywords: HPLC, RP-HPLC, Chromatography, Chromatographic Conditions, Abacavir (ABAC), Lamivudine (LAMI).

Authors: Dr. Priya Nair, Mr. Rohan Deshmukh

ABSTRACT: Patient-centric approaches in drug safety monitoring prioritize the involvement of patients in reporting adverse drug reactions (ADRs) and participating in pharmacovigilance activities. Recognizing patients as active stakeholders enhances the detection of drug-related risks and improves therapeutic outcomes. This paper explores the principles, methodologies, benefits, and challenges of patient-centric pharmacovigilance, emphasizing the integration of digital technologies, mobile applications, and real-world evidence. Tables summarizing patient engagement tools and reporting metrics are included. Implementing patient-focused strategies strengthens drug safety monitoring, enhances regulatory decision-making, and promotes patient empowerment in healthcare.

KEYWORDS: Patient-Centric, Pharmacovigilance, Adverse Drug Reactions, Drug Safety, Real-World Evidence, Patient Engagement

Authors: Dr. Kavita Sharma, Mr. Rohan Mehta

ABSTRACT: Pharmacovigilance in clinical trials plays a pivotal role in ensuring patient safety, drug efficacy, and ethical conduct during drug development. It encompasses systematic processes to monitor, identify, assess, and prevent adverse drug reactions (ADRs) throughout trial phases. The discipline not only addresses regulatory compliance but also strengthens clinical decision making and post-marketing surveillance. This paper explores the scope, challenges, regulatory frameworks, and technological advancements in pharmacovigilance during clinical trials, emphasizing its contribution to modern drug safety systems.

KEYWORDS: Pharmacovigilance, Clinical Trials, Adverse Drug Reactions, Regulatory Framework, Drug Safety

Authors: Dr. Neha Joshi, Mr. Aditya Singh

ABSTRACT: Global pharmacovigilance databases, including VigiBase, FAERS, and EudraVigilance, play a crucial role in monitoring drug safety across populations. These repositories collect and analyze adverse drug reactions (ADRs) reported by healthcare professionals, patients, and manufacturers. This paper discusses the structure, functionalities, and impact of these databases on drug safety surveillance, signal detection, and regulatory decision-making. It also highlights the challenges, such as data standardization, underreporting, and integration with national pharmacovigilance systems. Tables summarizing database characteristics and reporting metrics are included. Effective utilization of global pharmacovigilance databases enhances patient safety, informs regulatory actions, and supports the rational use of medicines worldwide.*

KEYWORDS: Pharmacovigilance, VigiBase, FAERS, EudraVigilance, Adverse Drug Reactions, Drug Safety, Signal Detection

Authors: Dr. Suman Verma, Mr. Anil Patel

ABSTRACT: Reporting and monitoring adverse drug reactions (ADRs) in developing countries present unique challenges due to limited healthcare infrastructure, lack of awareness, underreporting, and inconsistent regulatory frameworks. This paper examines the key barriers to effective pharmacovigilance in developing regions, including socio-economic, cultural, and technological factors. Current methods for ADR detection, strategies to enhance reporting, and potential interventions are discussed. Tables summarizing challenges, impacts, and solutions are included. Addressing these issues is critical to improve patient safety, ensure rational drug use, and strengthen national and global pharmacovigilance efforts.

KEYWORDS: Adverse Drug Reactions, Pharmacovigilance, Developing Countries, Underreporting, Drug Safety, Regulatory Challenges